SETDB2 and breast carcinoma: Immunoprecipitation showed that SETDB2 endogenously interacted with BUBR1 rather than MPS1, CDC20, or MAD2 in MCF7, MDA‐MB‐231, and SUM159PT breast cancer cells (Fig. 3A,B).